These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17849486)

  • 61. Immunophenotyping in leukaemias is not a luxury.
    Kurukulasuriya AP; Wijesiriwardene B; Perera TK
    Ceylon Med J; 1998 Jun; 43(2):117-8. PubMed ID: 9704557
    [No Abstract]   [Full Text] [Related]  

  • 62. Fluorescence intensity calibration for immunophenotyping by flow cytometry.
    Vogt RF; Whitfield WE; Henderson LO; Hannon WH
    Methods; 2000 Jul; 21(3):289-96. PubMed ID: 10873483
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia.
    Rossi E; Matutes E; Morilla R; Owusu-Ankomah K; Heffernan AM; Catovsky D
    Leukemia; 1996 Mar; 10(3):494-7. PubMed ID: 8642868
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An optimized whole blood method for flow cytometric measurement of ZAP-70 protein expression in chronic lymphocytic leukemia.
    Shankey TV; Forman M; Scibelli P; Cobb J; Smith CM; Mills R; Holdaway K; Bernal-Hoyos E; Van Der Heiden M; Popma J; Keeney M
    Cytometry B Clin Cytom; 2006 Jul; 70(4):259-69. PubMed ID: 16906581
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: a population-based Canadian cohort.
    Seftel MD; Demers AA; Banerji V; Gibson SB; Morales C; Musto G; Pitz MW; Johnston JB
    Leuk Res; 2009 Nov; 33(11):1463-8. PubMed ID: 19581000
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Appearance of the T-cell marker CD8 on B chronic lymphatic leukemia cells in long-term cultures.
    Farkas R; Ben-Efraim S; Manor Y; Zan-Bar I; Klajman A
    Cancer Immunol Immunother; 1991; 34(3):181-5. PubMed ID: 1836750
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Application of lymphocyte immunophenotyping in selected diseases.
    Marti GE; Fleisher TA
    Pathol Immunopathol Res; 1988; 7(5):319-37. PubMed ID: 3068665
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Holding on to the Matutes score while dropping FMC7: new opportunity from standardised approaches in multiparameter flow cytometry.
    Zhu J; Raimbault A; Sourdeau E; Maillon A; Mathis S; Capron C; Lemaire P; Ronez E; Moatti H; Jondeau K; Clauser S; Bardet V
    Br J Haematol; 2020 Aug; 190(4):e255-e258. PubMed ID: 32557566
    [No Abstract]   [Full Text] [Related]  

  • 69. Pitfalls of CD45 gating strategies in leukaemia immunophenotyping.
    Lock RJ; Virgo PF; Evely RS
    Clin Lab Haematol; 2003 Feb; 25(1):67. PubMed ID: 12542446
    [No Abstract]   [Full Text] [Related]  

  • 70. Immunological monitoring utilizing novel probes.
    Stewart CC; Stewart SJ
    Ann N Y Acad Sci; 1993 Mar; 677():94-112. PubMed ID: 8494251
    [No Abstract]   [Full Text] [Related]  

  • 71. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations.
    Stewart CC; Behm FG; Carey JL; Cornbleet J; Duque RE; Hudnall SD; Hurtubise PE; Loken M; Tubbs RR; Wormsley S
    Cytometry; 1997 Oct; 30(5):231-5. PubMed ID: 9383096
    [No Abstract]   [Full Text] [Related]  

  • 72. [Monoclonal antibodies BCA-16 against surface T-cell antigen in healthy persons and in patients with leukemia].
    Bulycheva TI; Novikova NN; Miterev GIu; Novikova MS
    Gematol Transfuziol; 1988 Dec; 33(12):45-7. PubMed ID: 3266166
    [No Abstract]   [Full Text] [Related]  

  • 73. OMIP-042: 21-color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral blood.
    Staser KW; Eades W; Choi J; Karpova D; DiPersio JF
    Cytometry A; 2018 Feb; 93(2):186-189. PubMed ID: 29288606
    [No Abstract]   [Full Text] [Related]  

  • 74. Centers for Disease Control programs in flow cytometric immunophenotyping.
    Gerber AR
    Ann N Y Acad Sci; 1993 Mar; 677():40-2. PubMed ID: 8388182
    [No Abstract]   [Full Text] [Related]  

  • 75. Standardizing immunophenotyping for the Human Immunology Project.
    Maecker HT; McCoy JP; Nussenblatt R
    Nat Rev Immunol; 2012 Feb; 12(3):191-200. PubMed ID: 22343568
    [TBL] [Abstract][Full Text] [Related]  

  • 76. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures.
    Stelzer GT; Marti G; Hurley A; McCoy P; Lovett EJ; Schwartz A
    Cytometry; 1997 Oct; 30(5):214-30. PubMed ID: 9383095
    [No Abstract]   [Full Text] [Related]  

  • 77. Flow cytometric analysis of cell surface antigen density.
    Robins RA
    Methods Mol Biol; 1998; 80():319-36. PubMed ID: 9664390
    [No Abstract]   [Full Text] [Related]  

  • 78. EuroFlow and its activities: Introduction to the special EuroFlow issue of The Journal of Immunological Methods.
    van Dongen JJM; O'Gorman MRG; Orfao A
    J Immunol Methods; 2019 Dec; 475():112704. PubMed ID: 31758969
    [No Abstract]   [Full Text] [Related]  

  • 79. False-Positive Light Chain Clonal Restriction by Flow Cytometry in Patients Treated With Alemtuzumab: Potential Pitfalls for the Misdiagnosis of B-Cell Neoplasms.
    Chen PP; Tormey CA; Eisenbarth SC; Torres R; Richardson SS; Rinder HM; Smith BR; Siddon AJ
    Am J Clin Pathol; 2019 Jan; 151(2):154-163. PubMed ID: 30307483
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multiparameter flow cytometric analysis of mononuclear cells from HIV-infected individuals.
    Moody DJ; Casavant CH; Fulwyler MJ; McHugh TM; Stites DP
    Cytometry Suppl; 1988; 3():44-7. PubMed ID: 3076366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.